Center for Virology and Vaccine Research (CVVR)
  • Home
  • Research
    • Research Programs
    • Flow Cytometry Core
    • HIV-1 Neutralizing Antibody Core
    • Catalyst Research Center
    • Principal Investigators
    • Instructors
  • People
    • Investigators
    • Instructors
  • Education
    • Academic Programs
    • Young Investigators
    • CVVR Seminar
    • Annual Visiting Professor
  • Publications
  • Units
    • Clinical Trials Unit
    • Clinical Trials Unit Team
    • Tissue Technologies Unit
  • News & Events
    • CVVR News
    • CVVR Events
  • Calendar
  • Contact
  • Click to open the search input field Click to open the search input field Search
  • Menu Menu
croicroi

Treatment With Gilead’s Vesatolimod Is Evaluated for Safety and Virologic and Immunologic Response Versus Placebo in Phase 1B HIV Functional Cure Study

2020-03-10/in News

— Results Presented at CROI 2020 Support Further Evaluation of Vesatolimod as Part of Investigational Curative Regimens Aimed at Achieving ART-Free Control of HIV —

https://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/croi_w360.png 166 360 Morgana Souza https://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.png Morgana Souza2020-03-10 14:50:072020-03-24 06:31:43Treatment With Gilead’s Vesatolimod Is Evaluated for Safety and Virologic and Immunologic Response Versus Placebo in Phase 1B HIV Functional Cure Study
Moderna

Cambridge biotech Moderna leads in the race for a coronavirus vaccine

2020-02-28/in News

The company has already produced an experimental medicine, but its CEO cautions that an approved treatment is more than a year away.

https://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/T5QO7LLGUZE5FN3NYV2UIVJEF4.jpg 683 1024 Morgana Souza https://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.png Morgana Souza2020-02-28 08:48:002020-04-06 11:46:09Cambridge biotech Moderna leads in the race for a coronavirus vaccine
BG logoBG logo

Warren introduces bill to transfer funding from border wall to efforts to combat coronavirus

2020-02-27/in News

Dr. Kathryn Stephenson, a Harvard Medical School professor  helped to develop Warren’s plan. Read Article

https://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/logo-bg-e1585758298241.jpg 157 595 Morgana Souza https://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.png Morgana Souza2020-02-27 13:08:072020-04-06 13:09:32Warren introduces bill to transfer funding from border wall to efforts to combat coronavirus
Katy Boston globe

Coronavirus vaccine updates: How long until it will be ready? Here’s what experts say

2020-02-27/in News

“Vaccines teach the body’s immune system to recognize and battle viruses and bacteria. They’re one of the most effective ways to prevent disease. Work is underway on a coronavirus vaccine, but you won’t feel the sting of one in your arm anytime soon, experts say.” Read Article

https://cvvr.hms.harvard.edu/wp-content/uploads/2020/02/katy-boston-glove-COVD19.png 238 298 Morgana Souza https://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.png Morgana Souza2020-02-27 10:48:492020-04-06 11:35:43Coronavirus vaccine updates: How long until it will be ready? Here’s what experts say
Harvard gazette news

A ‘call to duty’ to battle a deadly global threat

2020-02-25/in News

New coronavirus collaboration joins Boston’s biomed community and researchers in China. Read More

https://cvvr.hms.harvard.edu/wp-content/uploads/2020/02/0020_DepartmentofMicrobiology_0202.jpg 800 1200 Morgana Souza https://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.png Morgana Souza2020-02-25 10:48:322020-04-06 11:32:21A ‘call to duty’ to battle a deadly global threat

Cooperating to Combat Coronavirus

2020-02-24/in News

“IN THE LAST DAYS OF 2019 and the first days after the New Year, we started hearing about a pneumonia-like illness in China,” says Dan Barouch, an HMS professor of medicine and of immunology known for his anti-HIV work, whose lab has developed a platform for rapid vaccine development. (During the Zika virus outbreak of 2016, for example, his group was the first to report, within a month, a vaccine protective in animal models.) “When the genome of the virus was released on Friday, January 10, we started reviewing the sequence that same evening, working through the weekend. By Monday morning, we were ready to grow it.” Read more

https://cvvr.hms.harvard.edu/wp-content/uploads/2020/02/HARVxCV1xMA20_1x.jpg 376 300 Morgana Souza https://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.png Morgana Souza2020-02-24 14:38:282020-04-06 11:30:30Cooperating to Combat Coronavirus
image from WGBH video

Boston Researchers Take On The Challenge Of A Coronavirus Vaccine

2020-02-13/in News

Dr. Dan Barouch discusses the challenge of Corona virus on WGBH with Liz Neisloss. Read more

https://cvvr.hms.harvard.edu/wp-content/uploads/2020/02/Screen-Shot-2020-02-13-at-12.47.41-PM.png 556 556 Academic Web Pages https://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.png Academic Web Pages2020-02-13 12:59:412020-04-01 12:03:54Boston Researchers Take On The Challenge Of A Coronavirus Vaccine

Blazing a New Trail for HIV Research

2020-02-05/in News

With a $2 million gift, a pioneer propels Dan Barouch, MD, PhD’s groundbreaking HIV research

https://cvvr.hms.harvard.edu/wp-content/uploads/2020/02/Brit-headshot-Blazing-a-New-Trail-for-HIV-Research-article-BIDMC.jpg 251 150 Morgana Souza https://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.png Morgana Souza2020-02-05 12:32:572020-02-05 13:38:25Blazing a New Trail for HIV Research

Research round-up: Vaccines

2019-11-27/in News

A vaccine candidate for HIV steps into phase III trials, signs emerge that antibiotics impair vaccine performance, and other highlights from clinical trials and laboratory studies.

https://cvvr.hms.harvard.edu/wp-content/uploads/2019/12/Research-round-up-vaccines.jpg 530 800 Morgana Souza https://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.png Morgana Souza2019-11-27 13:27:422020-02-05 13:37:16Research round-up: Vaccines
vaccination image

Should you get vaccinated against these germs?

2019-09-11/in News

Outbreaks of some viral infections, including measles and hepatitis A, are increasing across the country.

https://cvvr.hms.harvard.edu/wp-content/uploads/2019/09/VaccinationroundupJPG.jpg 300 300 Dan Barouch https://cvvr.hms.harvard.edu/wp-content/uploads/2020/03/cvvr-header-banner-long-white-bg.png Dan Barouch2019-09-11 15:34:372020-02-05 13:20:04Should you get vaccinated against these germs?
Page 30 of 36«‹2829303132›»

Prinicpal Investigators

Malika Aid-Boudries, Ph.D.

Dan H. Barouch, M.D., Ph.D.

Ai-ris Yonekura Collier, M.D.

Alan N. Engelman, Ph.D.

Jonathan Gootenberg

Sizun Jiang,Ph.D.

Boris Juelg, M.D., Ph.D.

Pablo Penaloza-MacMaster, Ph.D.

R. Keith Reeves, Ph.D.

Sampa Santra, Ph.D.

Joern E. Schmitz, M.D.

Michael Seaman, Ph.D.

Omar K. Siddiqi, M.D., M.P.H.

Kathryn E. Stephenson, M.D., M.P.H.

CVVR

Center for Virology and Vaccine Research

3 Blackfan Circle
Boston, MA 02115 – USA

T 617.667.7000
F 617.735.4566
E CVVRcontact@bidmc.harvard.edu

CVVR Clinical Trials Unit

T 617.735.4610
E CVVRtrials@bidmc.harvard.edu
[DISPLAY_ULTIMATE_SOCIAL_ICONS]

Affiliates

Beth Israel Deaconess Medical Center

Harvard University School of Medicine

Participate in Clinical Studies
© Copyright Center for Virology and Vaccine Research. All rights reserved. Site by Academic Web Pages
  • Login
Scroll to top Scroll to top Scroll to top